Oncolytics Biotech
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCY and other ETFs, options, and stocks.About ONCY
Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolation of the reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.
ONCY Key Statistics
ONCY News
Oncolytics Biotech, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason McCarthy from Maxim Group maintained a Buy ra...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...
Oncolytics (ONCY) announced updates on enrollment progress, U.S. site expansion, and expected data readouts from the ongoing GOBLET trial evaluating pelareorep...
Analyst ratings
83%
of 6 ratingsMore ONCY News
Analyst Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on Oncolytics Biotech and keeping the price target at $5.00. Elevate Your Investing Strate...
If you have been following Oncolytics Biotech (NasdaqCM:ONCY), you likely noticed its stock has become a talking point after the company released fresh clinical...
